Global Personalized Medicine and Epigenomics Professional Survey Report 2021 Forecast to 2026

Code: RW00014533386
Multimarket Insight
Oct-2021
Life Sciences
152 Pages

Genomic or personalized medicines are?given to patients after collecting genomic information and associated data?such as the levels of RNA, proteins and various metabolites that are crucial factors in medical decision making for personalized medicine.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Personalized Medicine and Epigenomics industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Reagents
Kits
Instruments
Enzymes
Services

Market Segment by Product Application
Oncology
Non-Oncology
Cancer Drug Technology

Finally, the report provides detailed profile and data information analysis of leading company.
Abbott Laboratories
Emd Millipore
Astellas Pharmaceuticals
Affymetrix
Celgene Corp.
Agilent Technologies
Epigentex
Bio Vision
BAYER AG
Epigenomics AG
Johnson & Johnson
LES Laboratoires Servier
Envivo Pharmaceuticals (Forum Pharmaceutricals)
Naturewise Biotech & Medicals Corp.
Karus Therapeutics Limited
Illumina Inc.
Gilead Sciences
Merck
Laboratory Corp. Of America Holdings
Glaxosmithkline
Rubicon Genomics
Novartis Pharma AG
Roche Holding AG
Quest Diagnostics
Progen Pharmaceuticals Limited
Oncolys Biopharma Inc.
Takeda Pharmaceutical Company Limited
Orchid Chemicals & Pharmaceuticals Limited

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Personalized Medicine and Epigenomics consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Personalized Medicine and Epigenomics market by identifying its various subsegments.
3.Focuses on the key global Personalized Medicine and Epigenomics manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Personalized Medicine and Epigenomics with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Personalized Medicine and Epigenomics submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Personalized Medicine and Epigenomics Professional Survey Report Report 2021, Forecast to 2026

1 Market Study Overview
1.1 Study Objectives
1.2 Personalized Medicine and Epigenomics Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Personalized Medicine and Epigenomics Segment by Type
2.1.1 Reagents
2.1.2 Kits
2.1.3 Instruments
2.1.4 Enzymes
2.1.5 Services
2.2 Market Analysis by Application
2.2.1 Oncology
2.2.2 Non-Oncology
2.2.3 Cancer Drug Technology
2.3 Global Personalized Medicine and Epigenomics Market Comparison by Regions (2016-2026)
2.3.1 Global Personalized Medicine and Epigenomics Market Size (2016-2026)
2.3.2 North America Personalized Medicine and Epigenomics Status and Prospect (2016-2026)
2.3.3 Europe Personalized Medicine and Epigenomics Status and Prospect (2016-2026)
2.3.4 Asia-pacific Personalized Medicine and Epigenomics Status and Prospect (2016-2026)
2.3.5 South America Personalized Medicine and Epigenomics Status and Prospect (2016-2026)
2.3.6 Middle East & Africa Personalized Medicine and Epigenomics Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Personalized Medicine and Epigenomics Industry Impact
2.5.1 Personalized Medicine and Epigenomics Business Impact Assessment - Covid-19
2.5.2 Market Trends and Personalized Medicine and Epigenomics Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Personalized Medicine and Epigenomics Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Personalized Medicine and Epigenomics Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Personalized Medicine and Epigenomics Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Personalized Medicine and Epigenomics Manufacturer Market Share
3.5 Top 10 Personalized Medicine and Epigenomics Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Personalized Medicine and Epigenomics Market
3.7 Key Manufacturers Personalized Medicine and Epigenomics Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Personalized Medicine and Epigenomics Industry Key Manufacturers
4.1 Abbott Laboratories
4.1.1 Company Details
4.1.2 Abbott Laboratories Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.1.3 Abbott Laboratories Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Abbott Laboratories News
4.2 Emd Millipore
4.2.1 Company Details
4.2.2 Emd Millipore Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.2.3 Emd Millipore Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Emd Millipore News
4.3 Astellas Pharmaceuticals
4.3.1 Company Details
4.3.2 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.3.3 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Astellas Pharmaceuticals News
4.4 Affymetrix
4.4.1 Company Details
4.4.2 Affymetrix Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.4.3 Affymetrix Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Affymetrix News
4.5 Celgene Corp.
4.5.1 Company Details
4.5.2 Celgene Corp. Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.5.3 Celgene Corp. Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Celgene Corp. News
4.6 Agilent Technologies
4.6.1 Company Details
4.6.2 Agilent Technologies Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.6.3 Agilent Technologies Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Agilent Technologies News
4.7 Epigentex
4.7.1 Company Details
4.7.2 Epigentex Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.7.3 Epigentex Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.5 Epigentex News
4.8 Bio Vision
4.8.1 Company Details
4.8.2 Bio Vision Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.8.3 Bio Vision Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Bio Vision News
4.9 BAYER AG
4.9.1 Company Details
4.9.2 BAYER AG Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.9.3 BAYER AG Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 BAYER AG News
4.10 Epigenomics AG
4.10.1 Company Details
4.10.2 Epigenomics AG Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.10.3 Epigenomics AG Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 Epigenomics AG News
4.11 Johnson & Johnson
4.11.1 Company Details
4.11.2 Johnson & Johnson Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.11.3 Johnson & Johnson Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.11.4 Main Business Overview
4.11.5 Johnson & Johnson News
4.12 LES Laboratoires Servier
4.12.1 Company Details
4.12.2 LES Laboratoires Servier Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.12.3 LES Laboratoires Servier Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.12.4 Main Business Overview
4.12.5 LES Laboratoires Servier News
4.13 Envivo Pharmaceuticals (Forum Pharmaceutricals)
4.13.1 Company Details
4.13.2 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.13.3 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.13.4 Main Business Overview
4.13.5 Envivo Pharmaceuticals (Forum Pharmaceutricals) News
4.14 Naturewise Biotech & Medicals Corp.
4.14.1 Company Details
4.14.2 Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.14.3 Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.14.4 Main Business Overview
4.14.5 Naturewise Biotech & Medicals Corp. News
4.15 Karus Therapeutics Limited
4.15.1 Company Details
4.15.2 Karus Therapeutics Limited Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.15.3 Karus Therapeutics Limited Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.15.4 Main Business Overview
4.15.5 Karus Therapeutics Limited News
4.16 Illumina Inc.
4.16.1 Company Details
4.16.2 Illumina Inc. Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.16.3 Illumina Inc. Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.16.4 Main Business Overview
4.16.5 Illumina Inc. News
4.17 Gilead Sciences
4.17.1 Company Details
4.17.2 Gilead Sciences Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.17.3 Gilead Sciences Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.17.4 Main Business Overview
4.17.5 Gilead Sciences News
4.18 Merck
4.18.1 Company Details
4.18.2 Merck Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.18.3 Merck Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.18.4 Main Business Overview
4.18.5 Merck News
4.19 Laboratory Corp. Of America Holdings
4.19.1 Company Details
4.19.2 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.19.3 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.19.4 Main Business Overview
4.19.5 Laboratory Corp. Of America Holdings News
4.20 Glaxosmithkline
4.20.1 Company Details
4.20.2 Glaxosmithkline Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.20.3 Glaxosmithkline Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.20.4 Main Business Overview
4.20.5 Glaxosmithkline News
4.21 Rubicon Genomics
4.21.1 Company Details
4.21.2 Rubicon Genomics Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.21.3 Rubicon Genomics Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.21.4 Main Business Overview
4.21.5 Rubicon Genomics News
4.22 Novartis Pharma AG
4.22.1 Company Details
4.22.2 Novartis Pharma AG Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.22.3 Novartis Pharma AG Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.22.4 Main Business Overview
4.22.5 Novartis Pharma AG News
4.23 Roche Holding AG
4.23.1 Company Details
4.23.2 Roche Holding AG Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.23.3 Roche Holding AG Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.23.4 Main Business Overview
4.23.5 Roche Holding AG News
4.24 Quest Diagnostics
4.24.1 Company Details
4.24.2 Quest Diagnostics Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.24.3 Quest Diagnostics Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.24.4 Main Business Overview
4.24.5 Quest Diagnostics News
4.25 Progen Pharmaceuticals Limited
4.25.1 Company Details
4.25.2 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.25.3 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.25.4 Main Business Overview
4.25.5 Progen Pharmaceuticals Limited News
4.26 Oncolys Biopharma Inc.
4.26.1 Company Details
4.26.2 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.26.3 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.26.4 Main Business Overview
4.26.5 Oncolys Biopharma Inc. News
4.27 Takeda Pharmaceutical Company Limited
4.27.1 Company Details
4.27.2 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.27.3 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.27.4 Main Business Overview
4.27.5 Takeda Pharmaceutical Company Limited News
4.28 Orchid Chemicals & Pharmaceuticals Limited
4.28.1 Company Details
4.28.2 Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Introduction, Application and Specification
4.28.3 Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.28.4 Main Business Overview
4.28.5 Orchid Chemicals & Pharmaceuticals Limited News

5 Global Personalized Medicine and Epigenomics Sales Categorized by Regions
5.1 Global Personalized Medicine and Epigenomics Revenue, Sales and Market Share by Regions
5.1.1 Global Personalized Medicine and Epigenomics Sales and Market Share by Regions (2016-2021)
5.1.2 Global Personalized Medicine and Epigenomics Revenue and Market Share by Regions (2016-2021)
5.2 North America Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
5.3 Europe Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
5.4 Asia-pacific Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
5.5 South America Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
5.6 Middle East & Africa Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)

6 North America Personalized Medicine and Epigenomics Market Size Categorized by Countries
6.1 North America Personalized Medicine and Epigenomics Sales, Revenue and Market Share by Countries
6.1.1 North America Personalized Medicine and Epigenomics Sales (Volume) by Countries (2016-2021)
6.1.2 North America Personalized Medicine and Epigenomics Revenue by Countries (2016-2021)
6.1.3 United States Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
6.1.4 Canada Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
6.1.5 Mexico Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
6.2 North America Personalized Medicine and Epigenomics Revenue (Value) by Manufacturers
6.3 North America Personalized Medicine and Epigenomics Sales and Market Share by Type (2016-2021)
6.4 North America Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2021)

7 Europe Personalized Medicine and Epigenomics Market Size Categorized by Countries
7.1 Europe Personalized Medicine and Epigenomics Sales, Revenue and Market Share by Countries
7.1.1 Europe Personalized Medicine and Epigenomics Sales (Volume) by Countries (2016-2021)
7.1.2 Europe Personalized Medicine and Epigenomics Revenue by Countries (2016-2021)
7.1.3 Germany Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
7.1.4 UK Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
7.1.5 France Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
7.1.6 Russia Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
7.1.7 Italy Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
7.1.8 Spain Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
7.2 Europe Personalized Medicine and Epigenomics Revenue (Value) by Manufacturers
7.3 Europe Personalized Medicine and Epigenomics Sales and Market Share by Type (2016-2021)
7.4 Europe Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2021)

8 Asia-Pacific Personalized Medicine and Epigenomics Market Size Categorized by Countries
8.1 Asia-pacific Personalized Medicine and Epigenomics Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Personalized Medicine and Epigenomics Sales (Volume) by Countries (2016-2021)
8.1.2 Asia-pacific Personalized Medicine and Epigenomics Revenue by Countries (2016-2021)
8.1.3 China Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
8.1.4 South Korea Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
8.1.5 Japan Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
8.1.6 Australia Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
8.1.7 India Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
8.1.8 Southeast Asia Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
8.2 Asia-pacific Personalized Medicine and Epigenomics Revenue (Value) by Manufacturers
8.3 Asia-pacific Personalized Medicine and Epigenomics Sales and Market Share by Type (2016-2021)
8.4 Asia-pacific Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2021)

9 South America Personalized Medicine and Epigenomics Market Size Categorized by Countries
9.1 South America Personalized Medicine and Epigenomics Sales, Revenue and Market Share by Countries
9.1.1 South America Personalized Medicine and Epigenomics Sales (Volume) by Countries (2016-2021)
9.1.2 South America Personalized Medicine and Epigenomics Revenue by Countries (2016-2021)
9.1.3 Brazil Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
9.2 South America Personalized Medicine and Epigenomics Sales and Market Share by Type (2016-2021)
9.3 South America Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2021)

10 Middle East and Africa Personalized Medicine and Epigenomics Market Size Categorized by Countries
10.1 Middle East and Africa Personalized Medicine and Epigenomics Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Personalized Medicine and Epigenomics Sales (Volume) by Countries (2016-2021)
10.1.2 Middle East and Africa Personalized Medicine and Epigenomics Revenue by Countries (2016-2021)
10.1.3 GCC Countries Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
10.1.4 Turkey Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
10.1.5 Egypt Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
10.1.6 South America Personalized Medicine and Epigenomics Sales and Growth Rate (2016-2021)
10.2 Middle East and Africa Personalized Medicine and Epigenomics Sales and Market Share by Type
10.3 Middle East and Africa Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2021)

11 Global Personalized Medicine and Epigenomics Market Segment by Type
11.1 Global Personalized Medicine and Epigenomics Revenue, Sales and Market Share by Type (2016-2021)
11.1.1 Global Personalized Medicine and Epigenomics Sales and Market Share by Type (2016-2021)
11.1.2 Global Personalized Medicine and Epigenomics Revenue and Market Share by Type (2016-2021)
11.2 Reagents Sales Growth Rate and Price
11.2.1 Global Reagents Sales Growth Rate (2016-2021)
11.2.2 Global Reagents Price (2016-2021)
11.3 Kits Sales Growth Rate and Price
11.3.1 Global Kits Sales Growth Rate (2016-2021)
11.3.2 Global Kits Price (2016-2021)
11.4 Instruments Sales Growth Rate and Price
11.4.1 Global Instruments Sales Growth Rate (2016-2021)
11.4.2 Global Instruments Price (2016-2021)
11.5.1 Global Enzymes Sales Growth Rate (2016-2021)
11.5.2 Global Enzymes Price (2016-2021)
11.6 Services Sales Growth Rate and Price
11.6.1 Global Services Sales Growth Rate (2016-2021)
11.6.2 Global Services Price (2016-2021)

12 Global Personalized Medicine and Epigenomics Market Segment by Application
12.1 Global Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2021)
12.2 Oncology Sales Growth Rate (2016-2021)
12.3 Non-Oncology Sales Growth Rate (2016-2021)
12.4 Cancer Drug Technology Sales Growth Rate (2016-2021)

13 Global Personalized Medicine and Epigenomics Market Forecast
13.1 Global Personalized Medicine and Epigenomics Revenue, Sales and Growth Rate (2021-2026)
13.2 Personalized Medicine and Epigenomics Market Forecast by Regions (2021-2026)
13.2.1 North America Personalized Medicine and Epigenomics Market Forecast (2021-2026)
13.2.2 Europe Personalized Medicine and Epigenomics Market Forecast (2021-2026)
13.2.3 Asia-Pacific Personalized Medicine and Epigenomics Market Forecast (2021-2026)
13.2.4 South America Personalized Medicine and Epigenomics Market Forecast (2021-2026)
13.2.5 Middle East & Africa Personalized Medicine and Epigenomics Market Forecast (2021-2026)
13.3 Personalized Medicine and Epigenomics Market Forecast by Type (2021-2026)
13.3.1 Global Personalized Medicine and Epigenomics Sales Forecast by Type (2021-2026)
13.3.2 Global Personalized Medicine and Epigenomics Market Share Forecast by Type (2021-2026)
13.4 Personalized Medicine and Epigenomics Market Forecast by Application (2021-2026)
13.4.1 Global Personalized Medicine and Epigenomics Sales Forecast by Application (2021-2026)
13.4.2 Global Personalized Medicine and Epigenomics Market Share Forecast by Application (2021-2026)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Personalized Medicine and Epigenomics Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Personalized Medicine and Epigenomics Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture Personalized Medicine and Epigenomics
Figure Market Concentration Ratio and Market Maturity Analysis of Personalized Medicine and Epigenomics
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Personalized Medicine and Epigenomics Market Size by Type
Figure Global Market Share of Personalized Medicine and Epigenomics by Type in 2020
Figure Reagents Picture
Figure Kits Picture
Figure Instruments Picture
Figure Enzymes Picture
Figure Services Picture
Table Global Personalized Medicine and Epigenomics Market Size (Volume) by Application
Figure Oncology Picture
Figure Non-Oncology Picture
Figure Cancer Drug Technology Picture
Table Global Personalized Medicine and Epigenomics Comparison by Regions (M USD) 2016-2026
Figure Global Personalized Medicine and Epigenomics Market Size (Million US$) (2016-2026)
Figure North America Personalized Medicine and Epigenomics Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Personalized Medicine and Epigenomics Revenue (Million US$) Growth Rate (2016-2026)
Figure Asia-pacific Personalized Medicine and Epigenomics Revenue (Million US$) Growth Rate (2016-2026)
Figure South America Personalized Medicine and Epigenomics Revenue (Million US$) Growth Rate (2016-2026)
Figure Middle East & Africa Personalized Medicine and Epigenomics Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Personalized Medicine and Epigenomics Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Personalized Medicine and Epigenomics Sales by Manufacturer (2016-2021)
Figure Global Personalized Medicine and Epigenomics Sales Market Share by Manufacturer in 2020
Table Global Personalized Medicine and Epigenomics Revenue by Manufacturer (2016-2021)
Figure Global Personalized Medicine and Epigenomics Revenue Market Share by Manufacturer in 2020
Table Global Personalized Medicine and Epigenomics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Personalized Medicine and Epigenomics Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Personalized Medicine and Epigenomics Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Personalized Medicine and Epigenomics Market
Table Key Manufacturers Personalized Medicine and Epigenomics Product Type
Table Mergers & Acquisitions Planning
Table Abbott Laboratories Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Abbott Laboratories
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2016-2021
Table Abbott Laboratories Main Business
Table Abbott Laboratories Recent Development
Table Emd Millipore Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Emd Millipore
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Emd Millipore 2016-2021
Table Emd Millipore Main Business
Table Emd Millipore Recent Development
Table Astellas Pharmaceuticals Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Astellas Pharmaceuticals
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Astellas Pharmaceuticals 2016-2021
Table Astellas Pharmaceuticals Main Business
Table Astellas Pharmaceuticals Recent Development
Table Affymetrix Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Affymetrix
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Affymetrix 2016-2021
Table Affymetrix Main Business
Table Affymetrix Recent Development
Table Celgene Corp. Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Celgene Corp.
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celgene Corp. 2016-2021
Table Celgene Corp. Main Business
Table Celgene Corp. Recent Development
Table Agilent Technologies Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Agilent Technologies
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Agilent Technologies 2016-2021
Table Agilent Technologies Main Business
Table Agilent Technologies Recent Development
Table Epigentex Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Epigentex
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Epigentex 2016-2021
Table Epigentex Main Business
Table Epigentex Recent Development
Table Bio Vision Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Bio Vision
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bio Vision 2016-2021
Table Bio Vision Main Business
Table Bio Vision Recent Development
Table BAYER AG Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of BAYER AG
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of BAYER AG 2016-2021
Table BAYER AG Main Business
Table BAYER AG Recent Development
Table Epigenomics AG Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Epigenomics AG
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Epigenomics AG 2016-2021
Table Epigenomics AG Main Business
Table Epigenomics AG Recent Development
Table Johnson & Johnson Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Johnson & Johnson
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2016-2021
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table LES Laboratoires Servier Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of LES Laboratoires Servier
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of LES Laboratoires Servier 2016-2021
Table LES Laboratoires Servier Main Business
Table LES Laboratoires Servier Recent Development
Table Envivo Pharmaceuticals (Forum Pharmaceutricals) Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Envivo Pharmaceuticals (Forum Pharmaceutricals)
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Envivo Pharmaceuticals (Forum Pharmaceutricals) 2016-2021
Table Envivo Pharmaceuticals (Forum Pharmaceutricals) Main Business
Table Envivo Pharmaceuticals (Forum Pharmaceutricals) Recent Development
Table Naturewise Biotech & Medicals Corp. Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Naturewise Biotech & Medicals Corp.
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Naturewise Biotech & Medicals Corp. 2016-2021
Table Naturewise Biotech & Medicals Corp. Main Business
Table Naturewise Biotech & Medicals Corp. Recent Development
Table Karus Therapeutics Limited Company Profile
Table Personalized Medicine and Epigenomics Product Introduction, Application and Specification of Karus Therapeutics Limited
Table Personalized Medicine and Epigenomics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Karus Therapeutics Limited 2016-

Abbott Laboratories
Emd Millipore
Astellas Pharmaceuticals
Affymetrix
Celgene Corp.
Agilent Technologies
Epigentex
Bio Vision
BAYER AG
Epigenomics AG
Johnson & Johnson
LES Laboratoires Servier
Envivo Pharmaceuticals (Forum Pharmaceutricals)
Naturewise Biotech & Medicals Corp.
Karus Therapeutics Limited
Illumina Inc.
Gilead Sciences
Merck
Laboratory Corp. Of America Holdings
Glaxosmithkline
Rubicon Genomics
Novartis Pharma AG
Roche Holding AG
Quest Diagnostics
Progen Pharmaceuticals Limited
Oncolys Biopharma Inc.
Takeda Pharmaceutical Company Limited
Orchid Chemicals & Pharmaceuticals Limited

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE